| pubmed-article:12210877 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12210877 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:12210877 | lifeskim:mentions | umls-concept:C0013023 | lld:lifeskim |
| pubmed-article:12210877 | lifeskim:mentions | umls-concept:C0752105 | lld:lifeskim |
| pubmed-article:12210877 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:12210877 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:12210877 | pubmed:dateCreated | 2002-9-4 | lld:pubmed |
| pubmed-article:12210877 | pubmed:abstractText | There are few reports of positron emission tomography (PET) in juvenile parkinsonism (JP). We report on the results of (18)F-6-fluoro-L-dopa (FD) PET in a 14-year-old patient with JP of 5 years duration associated with atypical features. This is the youngest subject to be investigated to date. There was a severe asymmetric reduction in striatal FD uptake, with a rostrocaudal gradient in the putamen similar to that seen in adult-onset idiopathic parkinsonism. Extensive DNA analysis in this patient did not show mutations in the parkin gene. | lld:pubmed |
| pubmed-article:12210877 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12210877 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12210877 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12210877 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12210877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12210877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12210877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12210877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12210877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12210877 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12210877 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12210877 | pubmed:issn | 0885-3185 | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:BreakefieldXa... | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:KleinChristin... | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:LeungJoanneJ | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:CalneDonald... | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:StoesslA... | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:PalPramod KPK | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:HedrichKatyaK | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:SamiiAliA | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:LiebermanAbra... | lld:pubmed |
| pubmed-article:12210877 | pubmed:author | pubmed-author:NausiedaPaul... | lld:pubmed |
| pubmed-article:12210877 | pubmed:copyrightInfo | Copyright 2002 Movement Disorder Society | lld:pubmed |
| pubmed-article:12210877 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12210877 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:12210877 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12210877 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12210877 | pubmed:pagination | 789-94 | lld:pubmed |
| pubmed-article:12210877 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:meshHeading | pubmed-meshheading:12210877... | lld:pubmed |
| pubmed-article:12210877 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12210877 | pubmed:articleTitle | [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism. | lld:pubmed |
| pubmed-article:12210877 | pubmed:affiliation | Neurodegenerative Disorders Centre, Vancouver Hospital & Health Sciences Centre, University of British Columbia, Vancouver, British Columbia, Canada. | lld:pubmed |
| pubmed-article:12210877 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12210877 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:12210877 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:12210877 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
